Skip to main content
Top
Published in: Journal of Experimental & Clinical Cancer Research 1/2010

Open Access 01-12-2010 | Review

Current research in perineural invasion of cholangiocarcinoma

Authors: Fang-Zhen Shen, Bing-Yuan Zhang, Yu-Jie Feng, Zhuo-Xia Jia, Bing An, Chang-Chang Liu, Xi-Yun Deng, Anil D Kulkarni, Yun Lu

Published in: Journal of Experimental & Clinical Cancer Research | Issue 1/2010

Login to get access

Abstract

Background

Perineural invasion is a common path for cholangiocarcinoma (CCA) metastasis, and it is highly correlated with postoperative recurrence and poor prognosis. It is often an early event in a disease that is commonly diagnosed in advanced stages, and thus it could offer a timely therapeutic and diagnostic target if better understood. This article systematically reviews the progress of CCA neural invasion-related molecules.

Methods

Studies were identified by searching MEDLINE and PubMed databases for articles from January 1990 to December 2009, using the keywords "cholangiocarcinoma," "perineural invasion," "nerve growth factor"(NGF), "neural cell adhesion molecule" (NCAM), "matrix metalloproteinase"(MMP), "neurotransmitter," "acetylcholine" (Ach), and "transforming growth factor" (TGF)." Additional papers and book chapters were identified by a manual search of references from the key articles.

Results

From above we found that the molecules NGF, NCAM, MMP, Ach and TGF may have prognostic significance in, and offer clues to the mechanism of CCA neural invasion.

Conclusions

Cholangiocarcinoma's increasing worldwide incidence is especially poignant in view of both the lacking effective therapies, and the fact that it is commonly diagnosed in advanced stages. As CCA neural invasion often appears early, more complete characterization of its molecular pathology could lead to the identification of targets for the diagnosis and therapy of this devastating malignancy.
Literature
1.
go back to reference Khan SA, Taylor-Robinson SD, Toledano MB, Beck A, Elliott P, Thomas HC: Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol. 2002, 37: 806-813. 10.1016/S0168-8278(02)00297-0.CrossRef Khan SA, Taylor-Robinson SD, Toledano MB, Beck A, Elliott P, Thomas HC: Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol. 2002, 37: 806-813. 10.1016/S0168-8278(02)00297-0.CrossRef
2.
go back to reference Shaib YH, El-Serag HB, Davila JA, Morgan R, McGlynn KA: Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology. 2005, 128: 620-626. 10.1053/j.gastro.2004.12.048.CrossRef Shaib YH, El-Serag HB, Davila JA, Morgan R, McGlynn KA: Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology. 2005, 128: 620-626. 10.1053/j.gastro.2004.12.048.CrossRef
3.
go back to reference Taylor-Robinson SD, Toledano MB, Arora S, Keegan TJ, Hargreaves S, Beck A, et al: Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998. Gut. 2001, 48: 816-820. 10.1136/gut.48.6.816.CrossRef Taylor-Robinson SD, Toledano MB, Arora S, Keegan TJ, Hargreaves S, Beck A, et al: Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998. Gut. 2001, 48: 816-820. 10.1136/gut.48.6.816.CrossRef
4.
go back to reference Khan SA, Davidson BR, Goldin R, Pereira SP, Rosenberg WM, Taylor-Robinson SD, et al: Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut. 2002, 51: 1-9. 10.1136/gut.51.suppl_6.vi1.CrossRef Khan SA, Davidson BR, Goldin R, Pereira SP, Rosenberg WM, Taylor-Robinson SD, et al: Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut. 2002, 51: 1-9. 10.1136/gut.51.suppl_6.vi1.CrossRef
5.
go back to reference Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD: Cholangiocarcinoma. Lancet. 2005, 366: 1303-1314. 10.1016/S0140-6736(05)67530-7. PMID: 16214602CrossRef Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD: Cholangiocarcinoma. Lancet. 2005, 366: 1303-1314. 10.1016/S0140-6736(05)67530-7. PMID: 16214602CrossRef
6.
go back to reference Liu XF, Zhou XT, Zou SQ: An analysis of 680 cases of cholangiocarcinoma from 8 hospitals. Hepatobiliary Pancreat Dis Int. 2005, 4: 585-588. Liu XF, Zhou XT, Zou SQ: An analysis of 680 cases of cholangiocarcinoma from 8 hospitals. Hepatobiliary Pancreat Dis Int. 2005, 4: 585-588.
7.
go back to reference Nagakawa T, Kayahara M, Ueno K, Ohta T, Konishi I, Ueda N, et al: A clinicopathologic study on neural invasion in cancer of the pancreatic head. Cancer. 1992, 69: 930-935. 10.1002/1097-0142(19920215)69:4<930::AID-CNCR2820690416>3.0.CO;2-R.CrossRef Nagakawa T, Kayahara M, Ueno K, Ohta T, Konishi I, Ueda N, et al: A clinicopathologic study on neural invasion in cancer of the pancreatic head. Cancer. 1992, 69: 930-935. 10.1002/1097-0142(19920215)69:4<930::AID-CNCR2820690416>3.0.CO;2-R.CrossRef
8.
go back to reference Murakawa K, Tada M, Takada M, Tamoto E, Shindoh G, Teramoto K, et al: Prediction of lymph node metastasis and perineural invasion of biliary tract cancer by selected features from cDNA array data. J Surg Res. 2004, 122: 184-194. 10.1016/j.jss.2004.06.003.CrossRef Murakawa K, Tada M, Takada M, Tamoto E, Shindoh G, Teramoto K, et al: Prediction of lymph node metastasis and perineural invasion of biliary tract cancer by selected features from cDNA array data. J Surg Res. 2004, 122: 184-194. 10.1016/j.jss.2004.06.003.CrossRef
9.
go back to reference Nakagohri T, Asano T, Kinoshita H, Kenmochi T, Urashima T, Miura F, et al: Aggressive surgical resection for hilar-invasive and peripheral intrahepatic cholangiocarcinoma. World J Surg. 2003, 27: 289-293. 10.1007/s00268-002-6696-7.CrossRef Nakagohri T, Asano T, Kinoshita H, Kenmochi T, Urashima T, Miura F, et al: Aggressive surgical resection for hilar-invasive and peripheral intrahepatic cholangiocarcinoma. World J Surg. 2003, 27: 289-293. 10.1007/s00268-002-6696-7.CrossRef
10.
go back to reference Giuliani A, Caporale A, Di Bari M, Demoro M, Gozzo P, Corona M, et al: Maximum gastric cancer diameter as a prognostic indicator: univariate and multivariate analysis. J Exp Clin Cancer Res. 2003, 22: 531-538. Giuliani A, Caporale A, Di Bari M, Demoro M, Gozzo P, Corona M, et al: Maximum gastric cancer diameter as a prognostic indicator: univariate and multivariate analysis. J Exp Clin Cancer Res. 2003, 22: 531-538.
11.
go back to reference Natsis K, Paraskevas G, Papaziogas B, Agiabasis A: "Pes anserinus" of the right phrenic nerve innervating the serous membrane of the liver: a case report (anatomical study). Morphologie. 2004, 88: 203-205. 10.1016/S1286-0115(04)98150-7.CrossRef Natsis K, Paraskevas G, Papaziogas B, Agiabasis A: "Pes anserinus" of the right phrenic nerve innervating the serous membrane of the liver: a case report (anatomical study). Morphologie. 2004, 88: 203-205. 10.1016/S1286-0115(04)98150-7.CrossRef
12.
go back to reference Tsuneki K, Iehihara K: Electron microscope study of vertebrate liver innervation. Arch Histol Jpn. 1981, 44: 1-13.CrossRef Tsuneki K, Iehihara K: Electron microscope study of vertebrate liver innervation. Arch Histol Jpn. 1981, 44: 1-13.CrossRef
13.
go back to reference Duraker N, Sisman S, Can G: The significance of perineural invasion as a prognostic factor in patients with gastric carcinoma. Surg Today. 2003, 33: 95-100. 10.1007/s005950300020.CrossRef Duraker N, Sisman S, Can G: The significance of perineural invasion as a prognostic factor in patients with gastric carcinoma. Surg Today. 2003, 33: 95-100. 10.1007/s005950300020.CrossRef
14.
go back to reference Murakawa K, Tada M, Takada M, Tamoto E, Shindoh G, Teramoto K, et al: Prediction of lymph node metastasis and perineural invasion of biliary tract cancer by selected features from cDNA array data. J Surg Res. 2004, 122: 184-194. 10.1016/j.jss.2004.06.003.CrossRef Murakawa K, Tada M, Takada M, Tamoto E, Shindoh G, Teramoto K, et al: Prediction of lymph node metastasis and perineural invasion of biliary tract cancer by selected features from cDNA array data. J Surg Res. 2004, 122: 184-194. 10.1016/j.jss.2004.06.003.CrossRef
15.
go back to reference Gebhardt C, Meyer W, Reichel M, Wünsch PH: Prognostic factors in the operative treatment of ductal pancreatic carcinoma. Langenbecks Arch Surg. 2000, 385: 14-20. 10.1007/s004230050004.CrossRef Gebhardt C, Meyer W, Reichel M, Wünsch PH: Prognostic factors in the operative treatment of ductal pancreatic carcinoma. Langenbecks Arch Surg. 2000, 385: 14-20. 10.1007/s004230050004.CrossRef
16.
go back to reference Takahashi S, Hasebe T, Oda T, Sasaki S, Kinoshita T, Konishi M, et al: Extra-tumor perineural invasion predicts postoperative development of peritoneal dissemination in pancreatic ductal adenocarcinoma. Anticancer Res. 2001, 21: 1407-1412. Takahashi S, Hasebe T, Oda T, Sasaki S, Kinoshita T, Konishi M, et al: Extra-tumor perineural invasion predicts postoperative development of peritoneal dissemination in pancreatic ductal adenocarcinoma. Anticancer Res. 2001, 21: 1407-1412.
17.
go back to reference Lee MA, Park GS, Lee HJ, Jung JH, Kang JH, Hong YS, et al: Survivin expression and its clinical significance in pancreatic cancer. BMC Cancer. 2005, 5: 127-129. 10.1186/1471-2407-5-127.CrossRef Lee MA, Park GS, Lee HJ, Jung JH, Kang JH, Hong YS, et al: Survivin expression and its clinical significance in pancreatic cancer. BMC Cancer. 2005, 5: 127-129. 10.1186/1471-2407-5-127.CrossRef
18.
go back to reference Suzuki M, Takahashi T, Ouchi K, Matsuno S: Perineural tumor invasion and its relation with the lymphogenous spread in human and experimental carcinoma of bile duct. A computer-aided 3-D reconstruction study. Tohoku J Exp Med. 1994, 172: 17-28. 10.1620/tjem.172.17.CrossRef Suzuki M, Takahashi T, Ouchi K, Matsuno S: Perineural tumor invasion and its relation with the lymphogenous spread in human and experimental carcinoma of bile duct. A computer-aided 3-D reconstruction study. Tohoku J Exp Med. 1994, 172: 17-28. 10.1620/tjem.172.17.CrossRef
19.
go back to reference Khan OA, Alexiou C, Soomro I, Duffy JP, Morgan WE, Beggs FD: Pathological determinants of survival in node-negative oesophageal cancer. Br J Surg. 2004, 91: 1586-1591. 10.1002/bjs.4778.CrossRef Khan OA, Alexiou C, Soomro I, Duffy JP, Morgan WE, Beggs FD: Pathological determinants of survival in node-negative oesophageal cancer. Br J Surg. 2004, 91: 1586-1591. 10.1002/bjs.4778.CrossRef
20.
go back to reference Maxwell P, Hamilton PW, Sloan JM: Three-dimensional reconstruction of perineural invasion in carcinoma of the extrahepatic bile ducts. J Pathol. 1996, 180: 142-145. 10.1002/(SICI)1096-9896(199610)180:2<142::AID-PATH618>3.0.CO;2-6.CrossRef Maxwell P, Hamilton PW, Sloan JM: Three-dimensional reconstruction of perineural invasion in carcinoma of the extrahepatic bile ducts. J Pathol. 1996, 180: 142-145. 10.1002/(SICI)1096-9896(199610)180:2<142::AID-PATH618>3.0.CO;2-6.CrossRef
21.
go back to reference Anton ES, Weskamp G, Reichardt LF, Matthew WD: Nerve growth factor and its low-affinity receptor promote Schwann cell migration. Proc Natl Acad Sci USA. 1994, 91: 2795-2799. 10.1073/pnas.91.7.2795.CrossRef Anton ES, Weskamp G, Reichardt LF, Matthew WD: Nerve growth factor and its low-affinity receptor promote Schwann cell migration. Proc Natl Acad Sci USA. 1994, 91: 2795-2799. 10.1073/pnas.91.7.2795.CrossRef
22.
go back to reference Gigliozzi A, Alpini G, Baroni GS, Marucci L, Metalli VD, Glaser SS, et al: Nerve growth factor modulates the proliferative capacity of the intrahepatic biliary epithelium in experimental cholestasis. Gastroenterology. 2004, 127: 1198-1209. 10.1053/j.gastro.2004.06.023.CrossRef Gigliozzi A, Alpini G, Baroni GS, Marucci L, Metalli VD, Glaser SS, et al: Nerve growth factor modulates the proliferative capacity of the intrahepatic biliary epithelium in experimental cholestasis. Gastroenterology. 2004, 127: 1198-1209. 10.1053/j.gastro.2004.06.023.CrossRef
23.
go back to reference Moscatelli I, Pierantozzi E, Camaioni A, Siracusa G, Campagnolo L: p75 neurotrophin receptor is involved in proliferation of undifferentiated mouse embryonic stem cells. Exp Cell Res. 2009, 3220-3232. 10.1016/j.yexcr.2009.08.014. Moscatelli I, Pierantozzi E, Camaioni A, Siracusa G, Campagnolo L: p75 neurotrophin receptor is involved in proliferation of undifferentiated mouse embryonic stem cells. Exp Cell Res. 2009, 3220-3232. 10.1016/j.yexcr.2009.08.014.
24.
go back to reference Alvaro D, Mancino MG, Onori P, Franchitto A, Alpini G, Francis H, et al: Estrogens and the pathophysiology of the biliary tree. World J Gastroenterol. 2006, 12: 3537-3545. PMID: 16773710 Alvaro D, Mancino MG, Onori P, Franchitto A, Alpini G, Francis H, et al: Estrogens and the pathophysiology of the biliary tree. World J Gastroenterol. 2006, 12: 3537-3545. PMID: 16773710
25.
go back to reference Zhu Z, Kleeff J, Kayed H, Wang L, Korc M, Büchler MW, et al: Nerve growth factor and enhancement of proliferation, invasion, and tumorigenicity of pancreatic cancer cells. Mol Carcinog. 2002, 35: 138-147. 10.1002/mc.10083.CrossRef Zhu Z, Kleeff J, Kayed H, Wang L, Korc M, Büchler MW, et al: Nerve growth factor and enhancement of proliferation, invasion, and tumorigenicity of pancreatic cancer cells. Mol Carcinog. 2002, 35: 138-147. 10.1002/mc.10083.CrossRef
26.
go back to reference Hahn SA, Bartsch D, Schroers A, Galehdari H, Becker M, Ramaswamy A, et al: Mutations of the DPC4/Smad4 gene in biliary tract carcinoma. Cancer Res. 1998, 58: 1124-1126. Hahn SA, Bartsch D, Schroers A, Galehdari H, Becker M, Ramaswamy A, et al: Mutations of the DPC4/Smad4 gene in biliary tract carcinoma. Cancer Res. 1998, 58: 1124-1126.
27.
go back to reference Seki H, Tanaka J, Sato Y, Kato Y, Umezawa A, Koyama K: Neural cell adhesion molecule (NCAM) and perineural invasion in bile duct cancer. J Surg Oncol. 1993, 53: 78-83. 10.1002/jso.2930530205.CrossRef Seki H, Tanaka J, Sato Y, Kato Y, Umezawa A, Koyama K: Neural cell adhesion molecule (NCAM) and perineural invasion in bile duct cancer. J Surg Oncol. 1993, 53: 78-83. 10.1002/jso.2930530205.CrossRef
28.
go back to reference Nakanishi Y, Zen Y, Kondo S, Itoh T, Itatsu K, Nakanuma Y: Expression of cell cycle-related molecules in biliary premalignant lesions: biliary intraepithelial neoplasia and biliary intraductal papillary neoplasm. Hum Pathol. 2008, 39: 1153-1161. 10.1016/j.humpath.2007.11.018.CrossRef Nakanishi Y, Zen Y, Kondo S, Itoh T, Itatsu K, Nakanuma Y: Expression of cell cycle-related molecules in biliary premalignant lesions: biliary intraepithelial neoplasia and biliary intraductal papillary neoplasm. Hum Pathol. 2008, 39: 1153-1161. 10.1016/j.humpath.2007.11.018.CrossRef
29.
go back to reference Schreiber SC, Giehl K, Kastilan C, Hasel C, Mühlenhoff M, Adler G, et al: Polysialylated NCAM represses E-cadherin mediated cell-cell adhesion in pancreatic tumor cells. Gastroenterology. 2008, 134: 1555-1566. 10.1053/j.gastro.2008.02.023.CrossRef Schreiber SC, Giehl K, Kastilan C, Hasel C, Mühlenhoff M, Adler G, et al: Polysialylated NCAM represses E-cadherin mediated cell-cell adhesion in pancreatic tumor cells. Gastroenterology. 2008, 134: 1555-1566. 10.1053/j.gastro.2008.02.023.CrossRef
30.
go back to reference van Kempen LC, Rhee JS, Dehne K, Lee J, Edwards DR, Coussens LM: Epithelial carcinogenesis: dynamic interplay between neoplastic cells and their microenvironment. Differentiation. 2002, 70: 610-623. 10.1046/j.1432-0436.2002.700914.x.CrossRef van Kempen LC, Rhee JS, Dehne K, Lee J, Edwards DR, Coussens LM: Epithelial carcinogenesis: dynamic interplay between neoplastic cells and their microenvironment. Differentiation. 2002, 70: 610-623. 10.1046/j.1432-0436.2002.700914.x.CrossRef
31.
go back to reference Lynch CC, Matrislan LM: Matrix metalloproteinases in tumor-host cell communication. Differentiation. 2002, 70: 561-573. 10.1046/j.1432-0436.2002.700909.x.CrossRef Lynch CC, Matrislan LM: Matrix metalloproteinases in tumor-host cell communication. Differentiation. 2002, 70: 561-573. 10.1046/j.1432-0436.2002.700909.x.CrossRef
32.
go back to reference Zhao H, Davydova L, Mandich D, Cartun RW, Ligato S: S-100-positive nerve fibers in hepatocellular carcinoma and intrahepatic cholangiocarcinoma: an immunohistochemical study. Am J Clin Pathol. 2007, 127: 374-379. 10.1309/37RTWYAEPABYY410.CrossRef Zhao H, Davydova L, Mandich D, Cartun RW, Ligato S: S-100-positive nerve fibers in hepatocellular carcinoma and intrahepatic cholangiocarcinoma: an immunohistochemical study. Am J Clin Pathol. 2007, 127: 374-379. 10.1309/37RTWYAEPABYY410.CrossRef
33.
go back to reference Miwa S, Miyagawa S, Soeda J, Kawasaki S: Matrix metalloproteinase-7 expression and biologic aggressiveness of cholangiocellular carcinoma. Cancer. 2002, 94: 428-434. 10.1002/cncr.10235.CrossRef Miwa S, Miyagawa S, Soeda J, Kawasaki S: Matrix metalloproteinase-7 expression and biologic aggressiveness of cholangiocellular carcinoma. Cancer. 2002, 94: 428-434. 10.1002/cncr.10235.CrossRef
34.
go back to reference Kim HJ, Kim JS, Kang CD, Lee SJ, Kim JY, Yeon JE, et al: Expression of epidermal growth factor receptor, ErbB2 and matrix metalloproteinase-9 in hepatolithiasis and cholangiocarcinoma [article in Korean]. Korean J Gastroenterol. 2005, 45: 52-59. Kim HJ, Kim JS, Kang CD, Lee SJ, Kim JY, Yeon JE, et al: Expression of epidermal growth factor receptor, ErbB2 and matrix metalloproteinase-9 in hepatolithiasis and cholangiocarcinoma [article in Korean]. Korean J Gastroenterol. 2005, 45: 52-59.
35.
go back to reference Itatsu K, Sasaki M, Yamaguchi J, Ohira S, Ishikawa A, Ikeda H, et al: Cyclooxygenase-2 is involved in the up-regulation of matrix metalloproteinase-9 in cholangiocarcinoma induced by tumor necrosis factor-alpha. Am J Pathol. 2009, 174: 829-841. 10.2353/ajpath.2009.080012.CrossRef Itatsu K, Sasaki M, Yamaguchi J, Ohira S, Ishikawa A, Ikeda H, et al: Cyclooxygenase-2 is involved in the up-regulation of matrix metalloproteinase-9 in cholangiocarcinoma induced by tumor necrosis factor-alpha. Am J Pathol. 2009, 174: 829-841. 10.2353/ajpath.2009.080012.CrossRef
36.
go back to reference Itatsu K, Zen Y, Yamaguchi J, Ohira S, Ishikawa A, Ikeda H, et al: Expression of matrix metalloproteinase 7 is an unfavorable postoperative prognostic factor in cholangiocarcinoma of the perihilar, hilar, and extrahepatic bile ducts. Hum Pathol. 2008, 39: 710-709. 10.1016/j.humpath.2007.09.016.CrossRef Itatsu K, Zen Y, Yamaguchi J, Ohira S, Ishikawa A, Ikeda H, et al: Expression of matrix metalloproteinase 7 is an unfavorable postoperative prognostic factor in cholangiocarcinoma of the perihilar, hilar, and extrahepatic bile ducts. Hum Pathol. 2008, 39: 710-709. 10.1016/j.humpath.2007.09.016.CrossRef
37.
go back to reference Kanno N, Lesage G, Phinizy JL, Glaser S, Francis H, Alpini G: Stimulation of alpha2-adrenergic receptor inhibits cholangiocarcinoma growth through modulation of Raf-1 and B-Raf activities. Hepatology. 2002, 35: 1329-1340. 10.1053/jhep.2002.33330.CrossRef Kanno N, Lesage G, Phinizy JL, Glaser S, Francis H, Alpini G: Stimulation of alpha2-adrenergic receptor inhibits cholangiocarcinoma growth through modulation of Raf-1 and B-Raf activities. Hepatology. 2002, 35: 1329-1340. 10.1053/jhep.2002.33330.CrossRef
38.
go back to reference Kassahun WT, Günl B, Tannapfel A, Ungemach FR, Hauss J, Abraham G: Alpha1-and beta2-adrenoceptors in the human liver with mass-forming intrahepatic cholangiocarcinoma: density and coupling to adenylate cyclase and phospholipase C. Naunyn Schmiedebergs Arch Pharmacol. 2005, 372: 171-181. 10.1007/s00210-005-0017-2.CrossRef Kassahun WT, Günl B, Tannapfel A, Ungemach FR, Hauss J, Abraham G: Alpha1-and beta2-adrenoceptors in the human liver with mass-forming intrahepatic cholangiocarcinoma: density and coupling to adenylate cyclase and phospholipase C. Naunyn Schmiedebergs Arch Pharmacol. 2005, 372: 171-181. 10.1007/s00210-005-0017-2.CrossRef
39.
go back to reference Trombino S, Cesario A, Margaritora S, Granone P, Motta G, Falugi C, et al: Alpha7-nicotinic acetylcholine receptors affect growth regulation of human mesothelioma cells: role of mitogen-activated protein kinase pathway. Cancer Res. 2004, 64: 135-145. 10.1158/0008-5472.CAN-03-1672.CrossRef Trombino S, Cesario A, Margaritora S, Granone P, Motta G, Falugi C, et al: Alpha7-nicotinic acetylcholine receptors affect growth regulation of human mesothelioma cells: role of mitogen-activated protein kinase pathway. Cancer Res. 2004, 64: 135-145. 10.1158/0008-5472.CAN-03-1672.CrossRef
40.
go back to reference Wegener C, Hamasaka Y, Nässel DR: Acetylcholine increases intracellular Ca2+ via nicotinic receptors in cultured PDF-containing clock neurons of Drosophila. J Neurophysiol. 2004, 91: 912-923. 10.1152/jn.00678.2003.CrossRef Wegener C, Hamasaka Y, Nässel DR: Acetylcholine increases intracellular Ca2+ via nicotinic receptors in cultured PDF-containing clock neurons of Drosophila. J Neurophysiol. 2004, 91: 912-923. 10.1152/jn.00678.2003.CrossRef
41.
go back to reference Song P, Sekhon HS, Jia Y, Keller JA, Blusztajn JK, Mark GP, et al: Acetylcholine is synthesized by and acts as an autocrine growth factor for small cell lung carcinoma. Cancer Res. 2003, 63: 214-221. Song P, Sekhon HS, Jia Y, Keller JA, Blusztajn JK, Mark GP, et al: Acetylcholine is synthesized by and acts as an autocrine growth factor for small cell lung carcinoma. Cancer Res. 2003, 63: 214-221.
42.
go back to reference Elsing C, Hübner C, Fitscher BA, Kassner A, Stremmel W: Muscarinic acetylcholine receptor stimulation of biliary epithelial cells and its effect on bile secretion in the isolated perfused liver. Hepatology. 1997, 25: 804-813. 10.1002/hep.510250404.CrossRef Elsing C, Hübner C, Fitscher BA, Kassner A, Stremmel W: Muscarinic acetylcholine receptor stimulation of biliary epithelial cells and its effect on bile secretion in the isolated perfused liver. Hepatology. 1997, 25: 804-813. 10.1002/hep.510250404.CrossRef
43.
go back to reference Cheng K, Raufman JP: Bile acid-induced proliferation of a human colon cancer cell line is mediated by transactivation of epidermal growth factor receptors. Biochem Pharmacol. 2005, 70: 1035-1047. 10.1016/j.bcp.2005.07.023.CrossRef Cheng K, Raufman JP: Bile acid-induced proliferation of a human colon cancer cell line is mediated by transactivation of epidermal growth factor receptors. Biochem Pharmacol. 2005, 70: 1035-1047. 10.1016/j.bcp.2005.07.023.CrossRef
44.
go back to reference Conklin BS, Zhao W, Zhong DS, Chen C: Nicotine and cotinine up-regulate vascular endothelial growth factor expression in endothelial cells. Am J Pathol. 2002, 160: 413-418.CrossRef Conklin BS, Zhao W, Zhong DS, Chen C: Nicotine and cotinine up-regulate vascular endothelial growth factor expression in endothelial cells. Am J Pathol. 2002, 160: 413-418.CrossRef
45.
go back to reference Sher E, Codignola A, Passafaro M, Tarroni P, Magnelli V, Carbone E, et al: Nicotinic receptors and calcium channels in small cell lung carcinoma. Functional role, modulation, and autoimmunity. Ann N Y Acad Sci. 1998, 841: 606-624. 10.1111/j.1749-6632.1998.tb10993.x.CrossRef Sher E, Codignola A, Passafaro M, Tarroni P, Magnelli V, Carbone E, et al: Nicotinic receptors and calcium channels in small cell lung carcinoma. Functional role, modulation, and autoimmunity. Ann N Y Acad Sci. 1998, 841: 606-624. 10.1111/j.1749-6632.1998.tb10993.x.CrossRef
46.
go back to reference Bacon AL, Farrington SM, Dunlop MG: Mutation frequency in coding and non-coding repeat sequences in mismatch repair deficient cells derived from normal human tissue. Oncogene. 2001, 20: 7464-7471. 10.1038/sj.onc.1204973.CrossRef Bacon AL, Farrington SM, Dunlop MG: Mutation frequency in coding and non-coding repeat sequences in mismatch repair deficient cells derived from normal human tissue. Oncogene. 2001, 20: 7464-7471. 10.1038/sj.onc.1204973.CrossRef
47.
go back to reference Hirayama D, Fujimori T, Satonaka K, Nakamura T, Kitazawa S, Horio M, et al: Immunohistochemical study of epidermal growth factor and transforming growth factor-beta in the penetrating type of early gastric cancer. Hum Pathol. 1992, 23: 681-685. 10.1016/0046-8177(92)90325-W.CrossRef Hirayama D, Fujimori T, Satonaka K, Nakamura T, Kitazawa S, Horio M, et al: Immunohistochemical study of epidermal growth factor and transforming growth factor-beta in the penetrating type of early gastric cancer. Hum Pathol. 1992, 23: 681-685. 10.1016/0046-8177(92)90325-W.CrossRef
48.
go back to reference Eastham JA, Truong LD, Rogers E, Kattan M, Flanders KC, Scardino PT, et al: Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer. Lab Invest. 1995, 73: 628-35. Eastham JA, Truong LD, Rogers E, Kattan M, Flanders KC, Scardino PT, et al: Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer. Lab Invest. 1995, 73: 628-35.
49.
go back to reference Zhang BY, Zhang JY, Zhao K, Wu LQ: Expression of Smad4 and transforming growth factor-beta1, transforming growth factor-beta receptor II in cholangiocarcinoma tissue and its biological significance [abstract in English]. Zhonghua Wai Ke Za Zhi. 2005, 43: 846-849. Zhang BY, Zhang JY, Zhao K, Wu LQ: Expression of Smad4 and transforming growth factor-beta1, transforming growth factor-beta receptor II in cholangiocarcinoma tissue and its biological significance [abstract in English]. Zhonghua Wai Ke Za Zhi. 2005, 43: 846-849.
50.
go back to reference Lu Y, Wu LQ, Li CS, Wang SG, Han B: Expression of transforming growth factors in hepatocellular carcinoma and its relations with clinicopathological parameters and prognosis. Hepatobiliary Pancreat Dis Int. 2008, 7: 174-178. Lu Y, Wu LQ, Li CS, Wang SG, Han B: Expression of transforming growth factors in hepatocellular carcinoma and its relations with clinicopathological parameters and prognosis. Hepatobiliary Pancreat Dis Int. 2008, 7: 174-178.
51.
go back to reference Muraoka-Cook RS, Kurokawa H, Koh Y, Forbes JT, Roebuck LR, Barcellos-Hoff MH, et al: Conditional overexpression of active transforming growth factor beta1 in vivo accelerates metastases of transgenic mammary tumors. Cancer Res. 2004, 64: 9002-9011. 10.1158/0008-5472.CAN-04-2111.CrossRef Muraoka-Cook RS, Kurokawa H, Koh Y, Forbes JT, Roebuck LR, Barcellos-Hoff MH, et al: Conditional overexpression of active transforming growth factor beta1 in vivo accelerates metastases of transgenic mammary tumors. Cancer Res. 2004, 64: 9002-9011. 10.1158/0008-5472.CAN-04-2111.CrossRef
52.
go back to reference Zhuang DY, Liang P, Fan XH, Chen H: The expression and their significance of epidermal growth factor, transforming growth factor alpha and epidermal growth factor receptor during the intrahepatic cholangiocarcinoma carcinogenesis [Article in Chinese]. Zhonghua Gan Zang Bing Za Zhi. 2004, 12: 55- Zhuang DY, Liang P, Fan XH, Chen H: The expression and their significance of epidermal growth factor, transforming growth factor alpha and epidermal growth factor receptor during the intrahepatic cholangiocarcinoma carcinogenesis [Article in Chinese]. Zhonghua Gan Zang Bing Za Zhi. 2004, 12: 55-
53.
go back to reference Hormi K, Cadiot G, Kermorgant S, Dessirier V, Le Romancer M, Lewin MJ, et al: Transforming growth factor-alpha and epidermal growth factor receptor in colonic mucosa in active and inactive inflammatory bowel disease. Growth Factors. 2000, 18: 79-91. 10.3109/08977190009003235.CrossRef Hormi K, Cadiot G, Kermorgant S, Dessirier V, Le Romancer M, Lewin MJ, et al: Transforming growth factor-alpha and epidermal growth factor receptor in colonic mucosa in active and inactive inflammatory bowel disease. Growth Factors. 2000, 18: 79-91. 10.3109/08977190009003235.CrossRef
Metadata
Title
Current research in perineural invasion of cholangiocarcinoma
Authors
Fang-Zhen Shen
Bing-Yuan Zhang
Yu-Jie Feng
Zhuo-Xia Jia
Bing An
Chang-Chang Liu
Xi-Yun Deng
Anil D Kulkarni
Yun Lu
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Journal of Experimental & Clinical Cancer Research / Issue 1/2010
Electronic ISSN: 1756-9966
DOI
https://doi.org/10.1186/1756-9966-29-24

Other articles of this Issue 1/2010

Journal of Experimental & Clinical Cancer Research 1/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine